Patients with at least one antimicrobial | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Crude prevalence (%) | 95% CI | N | Crude prevalence (%) | 95% CI | N | Crude prevalence (%) | 95% CI | N | Crude prevalence (%) | 95% CI | |
Ward specialty | Total | Medicine | Surgery | ICU | ||||||||
All patients | 7577 | 27.1 | 26.5–27.6 | 4886 | 24.6 | 24.0–25.2 | 1988 | 29.6 | 28.5–30.7 | 703 | 51.0 | 48.4–53.7 |
Adultsa | 7095 | 27.1 | 26.6–27.7 | 4461 | 24.4 | 23.8–25.1 | 1966 | 29.4 | 28.3–30.5 | 668 | 55.1 | 52.3–57.9 |
Childrena | 430 | 32.4 | 29.9–34.9 | 393 | 31.6 | 29.0–34.2 | 22 | 47.8 | 33.4–62.3 | 15 | 38.5 | 23.2–53.7 |
Neonatesa | 52 | 9.8 | 7.3–12.3 | 32 | 7.9 | 5.3–10.5 | 0 | 20 | 15.8 | 9.4–22.1 | ||
Per antimicrobial subclass | ||||||||||||
A07AA | 59 | 0.21 | 0.16–0.26 | 52 | 0.26 | 0.19–0.33 | 2 | 0.03 | 0.00–0.07 | 5 | 0.36 | 0.05–0.68 |
D01BA | 6 | 0.02 | 0.00–0.04 | 4 | 0.02 | 0.00–0.04 | 2 | 0.03 | 0.00–0.07 | 0 | ||
J01 | 7323 | 26.2 | 25.6–26.7 | 4664 | 23.4 | 22.8–24.0 | 1973 | 29.3 | 28.3–30.4 | 686 | 49.8 | 47.1–52.4 |
J02 | 357 | 1.27 | 1.14–1.41 | 270 | 1.36 | 1.20–1.52 | 36 | 0.54 | 0.36–0.71 | 51 | 3.70 | 2.70–4.70 |
J04A | 79 | 0.28 | 0.22–0.34 | 41 | 0.21 | 0.14–0.27 | 35 | 0.52 | 0.35–0.69 | 3 | 0.22 | 0.00–0.46 |
J05b | 95 | 0.34 | 0.27–0.41 | 87 | 0.44 | 0.35–0.53 | 1 | 0.01 | 0.00–0.04 | 7 | 0.51 | 0.13–0.88 |
P01AB | 149 | 0.53 | 0.45–0.62 | 118 | 0.59 | 0.49–0.70 | 27 | 0.40 | 0.25–0.55 | 4 | 0.29 | 0.01–0.57 |
Per hospital typec | ||||||||||||
Primary | 4866 | 27.0 | 26.3–27.6 | 3135 | 24.4 | 23.6–25.1 | 1327 | 30.1 | 28.7–31.4 | 404 | 53.1 | 49.5–56.6 |
Secondary | 1768 | 26.1 | 25.0–27.1 | 1143 | 23.1 | 21.9–24.3 | 455 | 30.7 | 28.4–33.1 | 170 | 48.3 | 43.1–53.5 |
Tertiary | 907 | 29.5 | 27.9–31.1 | 583 | 28.9 | 26.9–30.9 | 203 | 24.8 | 21.9–27.8 | 121 | 51.0 | 44.7–57.4 |